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ABSTRACT Delivery of drugs and macromolecules into the
brain is a challenging problem, due in part to the blood–brain
barrier. In this article, we focus on the possibilities and
limitations of two infusion techniques devised to bypass the
blood–brain barrier: convection enhanced delivery (CED) and
retro-convection enhanced delivery (R-CED). CED infuses
fluid directly into the interstitial space of brain or tumor,
whereas R-CED removes fluid from the interstitial space,
which results in the transfer of drugs from the vascular
compartment into the brain or tumor. Both techniques have
shown promising results for the delivery of drugs into large
volumes of tissue. Theoretical approaches of varying complex-
ity have been developed to better understand and predict
brain interstitial pressures and drug distribution for these
techniques. These theoretical models of flow and diffusion
can only be solved explicitly in simple geometries, and spherical
symmetry is usually assumed for CED, while axial symmetry
has been assumed for R-CED. This perspective summarizes
features of these models and provides physical arguments and
numerical simulations to support the notion that spherical
symmetry is a reasonable approximation for modeling CED
and R-CED. We also explore the potential of multi-catheter
arrays for delivering and compartmentalizing drugs using CED
and R-CED.
KEY WORDS blood brain barrier . convection enhanced
delivery . finite element analysis . mathematical model . retro-
convection enhanced delivery
ABBREVIATIONS
CED convection enhanced delivery
ECF extracellular eluid
i.c. intracranial
ISF interstitial fluid
PDE partial differential equation
R-CED retro-convection enhanced delivery
s.c. subcutaneous
INTRODUCTION
Primary malignant brain tumors are a significant thera-
peutic challenge in spite of substantial advances in tumor
imaging, neurosurgery, and radiation therapy. The efficacy
of potent chemotherapy drugs is limited by biochemical
and physiological barriers, including poor drug delivery to
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the brain tumor mass and its peripheral regions (1–3), rapid
clearance from the brain extracellular space (4), high
intratumor pressure (5) and toxicity to normal brain tissue.
More effective patterning of fluid movement through the
tumor or diversion of fluid from entering normal brain
parenchyma could improve brain tumor therapy.
Over the past decade, convection enhanced delivery
(CED), employing a positive pressure infusion directly into
the brain, has shown promising results in both animal
models and clinical trials (6–9). CED distributes macro-
molecules, proteins, and particulate therapies into large
volumes of tissue (10–12). Retro-convection enhanced
delivery (R-CED), which removes interstitial fluid through
a microdialysis catheter (13), has also been introduced to
deliver drugs into brain tumors (14). Continuous flow of a
hyperosmotic high molecular weight polymer solution, as
the dialysate, drives fluid flow from the interstitial space
into the catheter, lowering interstitial pressure and leading
to convective flow of fluid, including drug, from capillaries
into tissue. By themselves or in combination, CED and R-
CED provide tools to pattern interstitial flow in the brain.
Fig. 1 illustrates CED and R-CED.
Theoretical approaches of varying complexity, ranging
from analytical to finite element models, have been
developed to better understand and predict the interstitial
distribution of material infused by CED (15–20). These
models have also been used to predict features such as the
interstitial fluid pressure, interstitial fluid velocity, tissue
swelling, and transvascular fluid exchange rate during
CED. Although these models do not recapitulate all aspects
of fluid distribution in the brain following CED, they are
instructive regarding what might be achieved in fluid
patterning by a multi-catheter infusion protocol.
Recently, Wang and Olbricht published an analysis of
R-CED driven by hydrostatic or osmotic flow across a
tubular microdialysis membrane (21). It was shown that
drug concentration near the catheter is enhanced when it
cannot permeate through the membrane, but such enhance-
ment is marginal when drug is permeable or semipermeable
in the membrane. Removal of drug into the catheter largely
defeats the purpose of R-CED, which is to draw drug into
brain or tumor tissue from the capillaries.
Analytical models of flow and diffusion for both CED
and R-CED can only be solved explicitly in simple
geometries, and spherical symmetry is usually assumed for
CED, while axial symmetry was assumed by Wang and
Olbricht for R-CED (21). Although real systems are more
complicated, in this article we provide physical arguments
and supporting numerical studies indicating that spherical
symmetry is a reasonable approximation in both CED and
R-CED. We also explore the potential benefits of fluid
delivery through multiple catheters. For example, drug-free
fluid flow out of one catheter can be used to divert drug-
containing fluid delivered from another catheter, offering
protection to tissue surrounding the first catheter. Thus,
drug delivered near the tumor/tissue interface might, in
principle, be localized on the tumor side, with a nonspherical,
nonsymmetric distribution. This idea is illustrated with a
simple phantom construct.
FLUID FLOW MODELING
Fluid Balance Equations
Following previous analyses, we utilize a simplified model-
ing approach in which fluid flow through tissue is described
by Darcy’s law,
u ¼ Krp ð1Þ
Fig. 1 Schematic illustration of fluid movement in the brain under the influence of CED or R-CED. a A CED catheter is implanted into the brain, and a
solution is perfused under a positive pressure (black arrows). The therapeutic solution convects in response to the pressure field. This allows permeation
and distribution of the therapeutic agent contained in the solution into the region of interest. b To remove fluid from the brain, a hyperosmotic solution is
perfused into the brain using a microdialysis probe. The microdialysis membrane separates the hyperosmotic perfusate from the brain interstitial. Fluid then
flows from the blood into the ISF and towards the microdialysis probe as diagrammed with the black arrows. The fluid then exits through the output tube
of the probe.
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and the equation for continuity of the fluid,
ϕr  u ϕLpcsðp peÞ ¼ 0 ð2Þ
where p is interstitial hydraulic pressure at a given location,
u is local (vector) fluid velocity, pe is effective or Starling
pressure of the capillary bed calculated according to
Starling’s law ðpe ¼ pc þ sðp  pcÞ, where pc and pc and
the intercapillary hydraulic and osmotic pressures, p is the
interstitial osmotic pressure, and s is the reflection coeffi-
cient of the capillary wall), φ is volume fraction of tissue
available for interstitial flow, s is capillary surface area per
unit volume of tissue, K is hydraulic conductivity of
interstitial space, and Lpc is the filtration coefficient of the
capillary walls.
The parameters pe, φ, s, k, and Lpc are all assumed to be
constant for a given tissue (e.g. brain parenchyma, tumor).
The velocity vector u is taken as a volume averaged field
variable, with volume averaging effects introduced at the
level of the Darcy coefficient, K. Combining Eqs. 1 and 2
obtains the equation for the difference between interstitial
and effective, Starling capillary pressure, ~p ¼ p pe
r2~p ¼ k2~p ð3Þ
where k ¼ ffiffiffiffiffiffiffiffiffiffiffiffiffiffiLpcs=K
p
has units of inverse distance.
Equation 3 is of the Helmholtz type. In the absence of
fluid exchange between tissue and capillaries (Lpc=0) it
reduces to Laplace’s equation, r2~p ¼ 0. More detailed
treatments also consider drug transport by diffusion and
exchange across capillary walls. Since our present interest is
fluid flow, these contributions to drug transport will not be
considered here.
CED and R-CED from a Spherically Symmetric
Catheter Tip
To denote the flow of drug solution through an idealized
spherically symmetricCEDcatheter tip of radiusRm and centered
at the origin by Q, using spherical coordinates to represent
position, i.e. r ¼ ðx; y; zÞ; rj j ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
x2 þ y2 þ z2
p
; ir ¼ r= rj j, the
velocity field around the source will be u ¼ uri, r>Rm.
Equations 3 and 1 become, respectively,
@2~p
@r2
þ 2
r
@~p
@r
¼ k2~p r > Rm ð4Þ
ur ¼ K @
~p
@r
r > Rm ð5Þ
Fluid flow continuity at the tip/tissue interface prescribes
the boundary condition
Q ¼ 4pR2mϕurðRmÞ ¼ 4pR2mfK
@~p
@r




r¼Rm
ð6Þ
Far from the tip, interstitial and capillary fluids are in
Starling equilibrium, i.e.
~pðrÞ ! 0; r !1 ð7Þ
The solution to Eqs. 4–7 is
~p ¼ Q
4pfKr
 
ekðrRmÞ
1þ kRm r > Rm ð8Þ
ur ¼ Q4pfr2
 
1þ kr
1þ kRm
 
ekðrRmÞ r > Rm ð9Þ
The terms in the square brackets refer to pressure and
flow that would occur in the absence of fluid exchange
between tissue and capillaries, i.e. k=0, (Laplace equation
solution). The remaining terms quantitate the relative
effects of fluid exchange compared to interstitial flow.
These terms rapidly decay to zero for r≫1/k and limit the
region of influence of flow from the catheter. The quantity
1/k is recognized as a “screening length” over which flow
across capillary walls buffers perturbations in pressure due
to infusion.
When tip radius is significantly smaller than the
screening length, i.e. κRm≪1, Eqs. 8 and 9 simplify to ~p ¼
qkekr=4pfKðkrÞ and ur ¼ ½qk2=4pfðkrÞ2ð1þ krÞekr,
respectively, for r>Rm. In this case, pressure and velocity
at a point beyond the tip surface decay according to the
number of screening lengths the point lies away from the
center of the tip.
To model R-CED, we must include the effects of the
dialysis membrane, whose hydraulic permeability will be
denoted by Lpm. We retain spherical symmetry in the
model. We assume, as will be argued below, that this
simplification will not lead to great error. Taking the
intercapillary Starling pressure as the reference, and
assuming that the osmolyte (e.g. high MW dextran) cannot
permeate through the dialysis membrane but all other
solutes can, the relevant pressure inside the catheter lumen
is ~pl ¼ pl  pl  pe where the subscript l refers to the
lumen. For R-CED, this pressure will be negative. Flow
continuity at the membrane/tissue interface warrants that
Lpm½~pl ~pðRmÞ ¼ ϕK
d~p
dr




r¼Rm
ð10Þ
474 Motion, Huynh, Szoka and Siegel
Replacing Eq. 6 with Eq. 11, the pressure and velocity
fields surrounding a spherical R-CED catheter become
~p ¼ ð1 qÞ Rm
r
 
ekðrRmÞ~pl ; ur
¼ ð1 qÞK Rm
r2
1þ kr
1þ kRm
 
ekðrRmÞ~pl
r > Rm
ð11Þ
where
q ¼ 1
1þ LpmRm=ϕK ð1þ kRmÞ ð12Þ
is the fraction of Starling pressure that is dissipated in the
membrane. The cases θ=0 and θ=1 correspond, respec-
tively, to membrane and tissue control of R-CED flow. For
κRm≪1, Eq. 11 simplifies to ~p ¼ ð1 qÞðRm=rÞekr~pl, .
Nonspherical Catheter Tips
Having presented equations for the idealized geometry, we
turn to the importance of precise tip geometry. For CED,
delivery is through the open end of a narrow shaft. For R-
CED, tubular microdialysis membranes are used, and Wang
and Olbricht’s work assumed cylindrical geometry. Calcu-
lations based on this assumption are strictly correct only for
catheters with large axis-to-radius ratios or when looking at
tissue that is very close to the catheter. We now argue that
spherical symmetry often provides a useful and reasonably
accurate approximation for CED and R-CED. This approx-
imation is commonly used in the electrostatics of colloidal
solutions, where the Helmholtz equation (linearized Poisson-
Boltzmann equation) is prominent (22,23).
Let d be the largest length scale of the catheter tip, such
as its radius or half its length. Also let the radial coordinate,
r, be a suitably chosen centroid of the catheter tip. Then
our assertion is, roughly, that spherical symmetry will apply
for r>d, and Eqs. 8, 9 and 11 will be good approximations.
For r<d, shape effects are more important.
To further support this assertion, several cases were
studied in the COMSOL 3.5a simulation environment
(COMSOL, Inc., Burlington MA), which solves partial
differential equations (PDEs), subject to appropriate bound-
ary conditions, using the finite element method. This
method, despite its approximations, is preferred over
analytic solutions. Even for the simple case of two ideal
spherical catheters delivering fluid at the same rate,
superposition does not provide a correct solution since
each catheter’s presence perturbs the flow pattern generated
by the other catheter.
To solve PDEs in COMSOL, a finite domain
corresponding to tissue is prescribed, as is the geometry of
the catheter(s). The type of equation (usually Helmholtz in
the present case) is then selected, and boundary conditions
are prescribed at the catheter surfaces and at the edges of
the domain. To minimize the effect of domain boundaries
on the numerical solution, the domain should be large
compared to catheter radius or length and distance
between the catheter’s tip. In the present simulations,
Dirichlet conditions (zero Starling pressure, similar to
Eq. 7) are prescribed at the domain boundary. Neumann
conditions (pertaining to pressure gradients) are prescribed
at catheter boundaries. Since we are only interested in
patterns, no attempt has been made to introduce physio-
logical parameters, flows magnitudes, or specific Starling
pressures.
As a first example, Fig. 2a shows that a cubic tip, with
fluid flowing uniformly and equally out of each face, is
surrounded by an essentially spherical pressure field, except
very close to the surface. Placed side by side with a
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Fig. 2 Finite element analysis of R-CED. a Finite element analysis of spherical and cubic “model” catheter tips. We designed objects with equal diameter
and set boundary conditions such that the flux emitting from the cube and the sphere are the same, and kRm=0.25. Pressure variations are represented
by color changes, and the arrows correspond to the direction of the velocity field with normalized magnitudes. b Finite element analysis of a CED catheter
tip fed by unidirectional plug flow with kRm=0.5. c Finite element analysis of R-CED Flow with kRm=0.5 and kd=4. The shaft tips are to be
impermeable, and the surrounding edges were modeled as model membranes. Relative pressures are mostly negative close to the membrane where
reverse flow is being generated.
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spherical tip with the two tips separated by a sufficient
distance that their interaction is small, and with equal flow
emerging from the two tips, the two objects produce
essentially identical pressure and flow fields away from
their surfaces, while fields near the surfaces depend on
shape. Fig. 2b shows simulations of delivery from a shaft,
with unidirectional flow to the lumen, which opens at its
end into the tissue. The outer body of the shaft is
impermeable to fluid flow. For simplicity, flow inside the
shaft is modeled as plug instead of Poisseiulle flow. This
figure demonstrates that a nearly spherically symmetric
pressure/flow profile develops soon after fluid leaves the
catheter tip, even though the tip itself is circular and shaft’s
wall blocks fluid flow. Intuitively, as one moves farther away
from the tip, the surface area of the isobar becomes larger
compared to the cross-sectional area of the shaft. The shaft
therefore becomes much less important in “shaping” the
front. Fig. 2c displays the flow pattern into a cylinder,
representing R-CED into a microdialysis membrane. The
axial/radial ratio is 8. Close to the membrane, the
(negative) pressure contours are nearly cylindrical, but they
round out as one moves away from the tube. With a smaller
value of k (larger 1/k), more such contours would be
discernable.
Multiple Catheter Delivery
The previous sections show that catheter shape has little
effect on pressure and flow profiles once fluid moves a
sufficient distance from the catheter tip. We now consider
the effects of flow from one catheter on flow from a second
catheter. The simplest situation is two identical catheters
placed at a distance from each other in a medium (tissue)
with uniform properties. Such a system is physically
modeled (see below) using an agarose gel phantom.
Suppose that one catheter delivers drug, while the other
delivers a drug-free, blank solution. If flows from the two
catheters are equal, then the flows will collide at the
“mirror” plane perpendicular to the two catheters and
proceed along that plane. This phenomenon is illustrated
by the flow arrows in Fig. 2a. Now suppose that flow from
the “blank” catheter is stronger. Then, the fluids will collide
along a surface that is closer to and bent around the drug-
delivering catheter. If the former and latter catheters are
properly placed inside and outside of the tumor, and flows
are properly selected, based on the tissue properties of
tumor and brain parenchyma (including differences in
tissue permeability, capillary densities and filtration coef-
ficients, and the absence of lymphatics in tumor, factors
which give rise to increased interstitial pressure in tumor), it
seems possible to focus drug delivery into the tumor and
substantially reduce exposure in the parenchyma. Conversely,
flow of a radioprotective agent from outside the tumor could
be “steered away” from tumor tissue by flow of blank solution
from a catheter inside the tumor.
A second possible dual probe configuration would
involve convective drug delivery from one catheter and
fluid removal by the other. Note that the latter catheter is
not used in the same way as has been previously considered
for R-CED, since drug is not being pulled out of the
circulation through capillaries, but rather is supplied by the
delivery catheter. In this case, flow is predicted from the
delivery catheter to the removal catheter, with a pattern
resembling the alignment of iron filings over two-pole
magnet. For reasons already identified by Wang and
Olbricht, this technique seems less promising than dual
CED, since it is more difficult to pull osmotically than it is
to push hydraulically, due to added hydraulic resistance
from the microdialysis membrane and tradeoffs between
osmotic pressure and viscosity of the dialysate (14), and
since drug will be lost into the removal catheter, unless that
catheter’s membrane is impermeable to drug.
DUAL PROBE CED IN AN AGAROSE GEL
PHANTOM
Dual probe CED experiments were carried out in an
agarose gel phantom by adapting methods that have been
described elsewhere for acute stereotactic infusion
(10,24,25). Bankiewicz and colleagues (26) have used a
similar system to visualize fluid distribution following single
probe CED. Briefly, cannulae were prepared from fused
silica tubing with an outer diameter of 0.16 mm (Polymicro
Technologies, Phoenix, AZ), extending 1–2 mm from the
tip of a 24 gauge needle used for support (26). Cannulae
were inserted into the 0.5% agarose gel (UltraPure
Agarose, 15510-019, Invitrogen, Carlsbad, CA), prepared
immediately before use, approximately 8 mm below the
surface of the gel, with tip outlets separated by 2 mm. An
external syringe pump (Bioanalytical Systems Inc., West
Lafayette, IN) was used to infuse solutions containing dyes
(67 kD albumin-Alexa Fluor 647 in one cannula and 3 kD
Texas Red-dextran in the other) at an increasing flow rate
as follow 0.1 mL/min for 5 min, 0.2 mL/min for 5 min,
0.5 mL/min for 5 min, and 0.8 mL/min for 30 min for a
total volume of 28 mL infused. Following the infusion, the
probes were removed slowly over 1 min. Photographs were
taken by slicing the agarose phantom and imaging on a
Kodak Imagestation 4000. Alexa Fluor 647 was visualized
individually using the 625 nm excitation filter and the
700 nm emission filter. Texas Red was visualized individ-
ually using the 535 nm excitation filter and the 600 nm
emission filter.
Fig. 3a shows the optical image of the two probes, with
Alexa Fluor in blue and Texas Red in red. Fluorescence
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images of individual probes are shown in Fig. 3b and c.
While a small amount of each probe may have flowed
upward around the cannulae, most flow was into the gel,
and the two dyes are located in nearly hemispheric regions,
indicating substantial nonoverlap of the flows. Close
inspection reveals, however, that the Texas Red moves a
little farther, and it “invades” the region that is predomi-
nantly Alexa Fluor. These observations are most likely due
to diffusion, which will be greater for Texas Red because of
its lower molecular weight.
CONCLUDING REMARKS
This paper has focused on the convective aspects of CED
and R-CED in the brain. We have argued that, for many
situations, both of these modalities can be modeled
reasonably well using simple spherically symmetric solutions
to the Helmholtz equation, which accounts for pressure and
flow fields around single cathethers.While real cathethers may
have different shapes, spherical fronts develop away from the
catheter. Because the volume of the spherical shells increases
as one moves away from the central source, the pressure and
flow fields for most of the affected tissue are relatively
insensitive to catheter shape, provided boundary conditions
such as total flow are properly set. Real-time imaging of CED
infusions into primate brains demonstrates that tip dimensions
and flow rates of currently used catheters in CED protocols
generate initial drug distribution with spherical symmetry in
homogeneous brain regions (27).
However, spherical symmetry is lost when the infused
volume reaches regions of the brain with different tissue
properties, leading to channeling effects and uneven drug
profiles. As a result, we must keep in mind that although
spherical symmetry is a valid approximation within homog-
enous tissue regions, anatomical differences in the brain can
alter expected drug profiles and concentrations. The model
for filtration across capillary walls is based on the classical
Starling hypothesis, with hydrostatic and osmotic pressures
inside the tissue assumed to be volume-averaged field
variables. A more recent interpretation of transcapillary wall
filtration suggests a more complex picture, however, with
concentration polarization of osmolytes adjacent to the
endothelial glycocalyx affecting osmotic flow (28). These
effects may alter the precise pressure and flow distributions
in tissue, but they are unlikely to alter the qualitative
behavior.
Although convection through tissue and filtration of fluid
across capillaries have been the main emphasis of this
paper, transport of drug by diffusion and by solvent drag
across capillary walls should be incorporated into more
complete descriptions (19–21). As suggested by the phan-
tom experiment, diffusion plays a noticeable but secondary
role in distribution of drug. Its effect is expected to be most
pronounced in regions where fluid flow is slow (low Peclet
number), i.e. away from the catheter, provided drug has not
been degraded or removed before reaching those regions.
We have also demonstrated the effect of dual catheters
in shaping flow fields and argued that by this means one
might steer chemotherapy out of regions of the brain where
toxic side effects could occur. Of course, one might consider
the effects of multiple catheters in generating drug delivery
patterns, subject to surgical constraints. Diffusion may blur the
boundaries between flow fields derived from neighboring
catheters, however, as illustrated in Fig. 3.
In addition to drug localization, drug patterning by
multiple catheters could be useful when drug should be
distributed through an entire brain region while sparing
critical tissues. This could be accomplished by infusing a non-
toxic saline solution into the critical area while simultaneously
infusing the drug into the larger regional space.
In order to enable such combination therapies, it will be
necessary to know the tissue properties in advance of
pattern planning or to use real-time imaging (9,27,29) such
that the infusion flow rates could be altered based on the
distribution of the ongoing infusion.
We conclude by suggesting further strategies which use
CED and R-CED. In one example, a rapidly eliminated
blood-brain-barrier-permeable drug could be administered
systemically, and a saline solution could be infused into the
tumor. The pressure of the saline infusion would reduce
drug extravasation into the tumor but would have no such
effect in normal tissue. Potential applications include the
infusion of radio- or cryoprotectants (30), whereby protectant
would accumulate in normal tissue, but tumor would remain
susceptible to radiation or cryo therapies.
Parameters governing transport in the brain may be
susceptible to manipulation, allowing for alteration in drug
Fig. 3 Dual probe CED in an agarose gel phantom. a Dispersion of
Alexa Fluor-albumin, MW 67 kD (blue) and Texas Red, MW 3 kD (red)
into agarose gel following equal rate volumetric infusion though identical
catheters, observed by optical microscopy. b Fluorescence image of Alexa
Fluor. c Fluorescence image of Texas Red.
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distribution. For example, interstitial hydraulic conductivity
might be altered using enzymes such as hyaluronidase to
degrade the extracellular matrix (31). Capillary permeability,
on the other hand, might be altered by angiogenesis
regulators such as VEGF. Such alterations, in addition to
changing the region of influence of a catheter, might alter
the pressure requirements on catheters to establish a desired
drug distribution.
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